101 related articles for article (PubMed ID: 25667146)
1. Preliminary Testing of a Patient-Reported Outcome Measure for Recurrent or Metastatic Head and Neck Cancer.
Jackson LK; Deng J; Ridner SH; Gilbert J; Dietrich MS; Murphy BA
Am J Hosp Palliat Care; 2016 May; 33(4):313-20. PubMed ID: 25667146
[TBL] [Abstract][Full Text] [Related]
2. Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health.
Cooperstein E; Gilbert J; Epstein JB; Dietrich MS; Bond SM; Ridner SH; Wells N; Cmelak A; Murphy BA
Head Neck; 2012 Jun; 34(6):797-804. PubMed ID: 22127786
[TBL] [Abstract][Full Text] [Related]
3. Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation.
Murphy BA; Dietrich MS; Wells N; Dwyer K; Ridner SH; Silver HJ; Gilbert J; Chung CH; Cmelak A; Burkey B; Yarbrough WG; Sinard R; Netterville J
Head Neck; 2010 Jan; 32(1):26-37. PubMed ID: 19626644
[TBL] [Abstract][Full Text] [Related]
4. Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment.
Kolnick L; Deng J; Epstein JB; Migliorati CA; Rezk J; Dietrich MS; Murphy BA
Oral Oncol; 2014 Feb; 50(2):135-40. PubMed ID: 24239279
[TBL] [Abstract][Full Text] [Related]
5. The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT).
Maddalo M; Buglione M; Pasinetti N; Triggiani L; Costa L; Magrini SM; Murphy BA
Radiol Med; 2020 Feb; 125(2):228-235. PubMed ID: 31784925
[TBL] [Abstract][Full Text] [Related]
6. The Vanderbilt Head and Neck Symptom Survey Brazilian Portuguese version 2.0 (VHNSS 2.0): psychometric properties for patients with head and neck cancer who have undergone radiotherapy.
Barroso EM; Carvalho AL; Paiva CE; Murphy BA; Paiva BS
BMC Res Notes; 2015 Oct; 8():522. PubMed ID: 26428472
[TBL] [Abstract][Full Text] [Related]
7. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
Rosenthal DI; Mendoza TR; Chambers MS; Asper JA; Gning I; Kies MS; Weber RS; Lewin JS; Garden AS; Ang KK; S Wang X; Cleeland CS
Head Neck; 2007 Oct; 29(10):923-31. PubMed ID: 17358040
[TBL] [Abstract][Full Text] [Related]
8. Vanderbilt head and neck symptom survey, version 2.0: Clinical and research utility for identification of symptom clusters and changes in symptoms over time.
Ridner SH; Rhoten BA; Niermann KJ; Murphy BA; Dietrich MS
Oral Oncol; 2018 Aug; 83():25-31. PubMed ID: 30098775
[TBL] [Abstract][Full Text] [Related]
9. Internal Lymphedema Correlates with Subjective and Objective Measures of Dysphagia in Head and Neck Cancer Patients.
Jackson LK; Ridner SH; Deng J; Bartow C; Mannion K; Niermann K; Gilbert J; Dietrich MS; Cmelak AJ; Murphy BA
J Palliat Med; 2016 Sep; 19(9):949-56. PubMed ID: 27227341
[TBL] [Abstract][Full Text] [Related]
10. A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice.
Maddalo M; Buglione M; Pasinetti N; Triggiani L; Pegurri L; Magli A; Magrini SM; Murphy BA
Radiol Med; 2020 Apr; 125(4):423-431. PubMed ID: 31925705
[TBL] [Abstract][Full Text] [Related]
11. PROMIS evaluation for head and neck cancer patients: a comprehensive quality-of-life outcomes assessment tool.
Stachler RJ; Schultz LR; Nerenz D; Yaremchuk KL
Laryngoscope; 2014 Jun; 124(6):1368-76. PubMed ID: 24719292
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
13. Depression among long-term survivors of head and neck cancer treated with radiation therapy.
Chen AM; Daly ME; Vazquez E; Courquin J; Luu Q; Donald PJ; Farwell DG
JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):885-9. PubMed ID: 23949013
[TBL] [Abstract][Full Text] [Related]
14. Sociocultural adaptation, translation and pre-testing of the Kannada version of Vanderbilt Head and Neck Symptom Survey 2.0.
Johnson N; Varghese JJ; Sharan K; Aithal VU; Murphy B
J Patient Rep Outcomes; 2022 Nov; 6(1):118. PubMed ID: 36434274
[TBL] [Abstract][Full Text] [Related]
15. To treat or not to treat: balancing therapeutic outcomes, toxicity and quality of life in patients with recurrent and/or metastatic head and neck cancer.
Murphy BA
J Support Oncol; 2013 Dec; 11(4):149-59. PubMed ID: 24645334
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial effects in long-term head and neck cancer survivors.
Holloway RL; Hellewell JL; Marbella AM; Layde PM; Myers KB; Campbell BH
Head Neck; 2005 Apr; 27(4):281-8. PubMed ID: 15668929
[TBL] [Abstract][Full Text] [Related]
17. Physical and psychosocial correlates of head and neck cancer: a review of the literature.
De Boer MF; McCormick LK; Pruyn JF; Ryckman RM; van den Borne BW
Otolaryngol Head Neck Surg; 1999 Mar; 120(3):427-36. PubMed ID: 10064650
[TBL] [Abstract][Full Text] [Related]
18. Differences of symptoms in head and neck cancer patients with and without lymphedema.
Deng J; Murphy BA; Dietrich MS; Sinard RJ; Mannion K; Ridner SH
Support Care Cancer; 2016 Mar; 24(3):1305-16. PubMed ID: 26314703
[TBL] [Abstract][Full Text] [Related]
19. Studies in the quality of life of head and neck cancer patients: results of a two-year longitudinal study and a comparative cross-sectional cross-cultural survey.
Morton RP
Laryngoscope; 2003 Jul; 113(7):1091-103. PubMed ID: 12838004
[TBL] [Abstract][Full Text] [Related]
20. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
